CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Potential Role for a Panel of Immunohistochemical Markers in the Management of Endometrial Carcinoma

Amany Salama, Mohammad Arafa, Eman ElZahaf, Abdelhadi Mohamed Shebl, Azmy Abd El-Hameed Awad, Sylvia A. Ashamallah, Reda Hemida, Anas Gamal, Abd AlRahman Foda, Khaled Zalata, El-Said M. Abdel-Hady

JPTM. 2019;53(3):164-172. Published online 2019 February 28 DOI: https://doi.org/10.4132/jptm.2019.02.12

Potential Role for a Panel of Immunohistochemical Markers in the Management of Endometrial Carcinoma

Amany Salama, Mohammad Arafa, Eman ElZahaf, Abdelhadi Mohamed Shebl, Azmy Abd El-Hameed Awad, Sylvia A. Ashamallah, Reda Hemida, Anas Gamal, Abd AlRahman Foda, Khaled Zalata, El-Said M. Abdel-Hady

Journal of Pathology and Translational Medicine. 2019;53(3):164-172

Link1

Link2 Link3

Immunohistochemical Markers in Endometrial Carcinoma

Bojana Djordjevic, Russell R. Broaddus

Precision Molecular Pathology of Uterine Cancer. 2017;43-63

Link1

Undifferentiated endometrial carcinoma: A selected immunohistochemical panel including PAX-8 and E-cadherin for aiding distinction from other endometrial carcinomas

Xiaofei Zhang, Minghua Yu

Annals of Diagnostic Pathology. 2019;39:36-41

Link1 Link2

Immunohistochemical Markers in Endometrial Cancer

Valerio Mais, Michele Peiretti

Cancers. 2021;13(3):505

Link1

High density of peritumoral lymphatic vessels is a potential prognostic marker of endometrial carcinoma: a clinical immunohistochemical method study

Ying Gao, Zi Liu, Fei Gao, Xiao-yu Meng

BMC Cancer. 2010;10(1):

Link1

Link2 Link3

Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinoma*

Thaer Khoury, Dongfeng Tan, Jianmin Wang, Marilyn Intengan, Jun Yang, Sadir Alrawi, Peisha Yan, James C Byrd

BMC Clinical Pathology. 2006;6(1):

Link1

Link2 Link3 Link4

Immunohistochemical assessment of p170 provides prognostic information in endometrial carcinoma

Bonatz, Lüttes, Hamann, Mettler, Jonat, Parwaresch

Histopathology. 1999;34(1):43-50

Link1 Link2 Link3

Supervised clustering of immunohistochemical markers to distinguish atypical endometrial hyperplasia from grade 1 endometrial cancer

Enora Laas, Marcos Ballester, Annie Cortez, Julie Gonin, Emile Daraï, Olivier Graesslin

Gynecologic Oncology. 2014;133(2):205-210

Link1 Link2

Immunohistochemical detection of histone deacetylases in endometrial carcinoma: involvement of histone deacetylase 2 in the proliferation of endometrial carcinoma cells

Hussein Fakhry, Tsutomu Miyamoto, Hiroyasu Kashima, Akihisa Suzuki, He Ke, Ikuo Konishi, Tanri Shiozawa

Human Pathology. 2010;41(6):848-858

Link1 Link2

Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma

X Zhu

Gynecologic Oncology. 2004;92(1):71-79

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. J Pathol Transl Med has participated in CrossRef Text and Data Mining service since January 16, 2015.